Cargando…
Reviving the role of MET in liver cancer therapy and vaccination: an autophagic perspective
Past failures in clinical trials have dampened the enthusiasm for studying the HGF receptor MET and postponed the development of MET-targeted drugs for cancer therapy. However, new evidence suggests that, at least in liver cancer, MET is still a promising therapeutic target, and may also be a potent...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781811/ https://www.ncbi.nlm.nih.gov/pubmed/33457099 http://dx.doi.org/10.1080/2162402X.2020.1818438 |